美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

iShares Health Innovation Active ETF

33.21

+0.24580.75%

盘后：33.17-0.0408-0.12%16:10 EDT

成交量：534

成交额：1.77万

市值：1,328.43万

市盈率：- -

高：33.21

开：33.11

低：33.11

收：32.97

52周最高：34.86

52周最低：25.79

股本：40.00万

流通股本：40.00万

量比：0.27

换手率：0.13%

股息：0.08

股息率：0.25%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

海西新药：已提交自研创新药HX9428临床试验申请

诺华集团：高效口服BTK抑制剂瑞米布替尼在III期RMS临床试验中显著降低复发率安全性表现良好

苏州市委书记范波会见强生执行副总裁史明德一行

南方财经网

众生药业(002317.SZ)：昂拉地韦片新增适应症临床试验申请获受理

范波会见强生执行副总裁史明德一行，共同出席强生苏州20周年活动

国家药监局正式启动滴眼剂一致性评价工作

单日暴涨177%的莫德纳，对全球医药产业意味着什么？

澳大利亚批准金佰利·克拉克收购肯维尤，但要求其剥离“Carefree”和“Stayfree”品牌

澳大利亚批准金佰利·克拉克收购肯维尤，但要求其剥离“Carefree”和“Stayfree”品牌

世卫组织：尔韦博疫苗目前仅应在研究方案框架内用于本迪布焦病毒（BVDV）

石药集团(01093.HK)：SYH2056片用于治疗抑郁症的I期临床试验在中国正式启动

智飞生物(300122.SZ)：冻干人用狂犬病疫苗(ZFB-3细胞)临床试验申请获受理

中关村(000931.SZ)下属公司盐酸哌甲酯缓释咀嚼片获批开展临床试验

智飞生物：智飞龙科马疫苗临床试验申请获受理，60日内可开展

中关村：北京华素40mg盐酸哌甲酯缓释咀嚼片获准开展临床试验

诺华制药(NVS.US)神经免疫管线“悲喜交加”：患者死亡致CAR-T临床试验暂停 MS口服药后期试验告捷

默克集团股价上涨2.6%，此前汇丰银行将其评级从持有上调至买入。

吉伦泰研制的靶向整合素αvβ3治疗核药获得国家药监局临床试验批件

美国医疗保险和医疗补助服务中心：将为阿肯色州农村医院提供资金，用于升级救护车、拓展远程医疗服务并安装应急发电机

特朗普政府宣布拨款1.493亿美元，用于在阿肯色州农村地区扩展远程医疗，并增加专科护理和预防性筛查的可及性。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/BMED/news?page=6"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":33.2108,"timestamp":1789416000000,"preClose":32.965,"halted":0,"volume":534,"hourTrading":{"tag":"盘后","latestPrice":33.17,"preClose":33.2108,"latestTime":"16:10 EDT","volume":7,"amount":232.554,"timestamp":1789416603529,"change":-0.0408,"changeRate":-0.001229,"amplitude":0},"delay":0,"changeRate":0.00745639314424376,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"未开盘","change":0.2458,"latestTime":"09-14 16:00:00 EDT","open":33.11,"high":33.2108,"low":33.11,"amount":17725,"amplitude":0.003058,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":32.965,"sharesOutstanding":360000,"nav":32.890304,"aum":13156121.6,"dividendRate":0.0024,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.17,"preClose":33.2108,"latestTime":"16:10 EDT","volume":7,"amount":232.554,"timestamp":1789416603529,"change":-0.0408,"changeRate":-0.001229,"amplitude":0},"volumeRatio":0.273566,"impliedVol":0.068,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.273566,"shares":400000,"dividePrice":0.0826,"high":33.2108,"amplitude":0.003058,"preClose":32.965,"low":33.11,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":33.2108,"eps":0,"divideRate":0.002487,"volume":534,"delay":0,"ttmEps":0,"open":33.11,"prevYearClose":30.32,"prevWeekClose":32.965,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":34.0304,"twentyDayClose":32.17,"sixtyDayClose":28.4912},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664819950","title":"海西新药：已提交自研创新药HX9428临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819950","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819950?lang=zh_cn&edition=fundamental","pubTime":"2026-09-02 19:53","pubTimestamp":1788349980,"startTime":"0","endTime":"0","summary":"9月2日，海西新药（02637）发布公告，公司自主研发的创新药项目HXP056之候选药物分子HX9428，已于2026年8月31日正式向国家药监局药品审评中心递交新适应症糖尿病性黄斑水肿的IIa期新药临床试验申请。HX9428是海西新药自主研发的全新口服小分子创新药物，拟用于治疗nAMD、DME及RVO等血管性视网膜相关疾病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609023862943252.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609023862943252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","PSYK","BK1161","IBBJ","IBBQ","BMED","BK1574","MDTX","LNGR","159992","MEDX","06978","02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815045","title":"诺华集团：高效口服BTK抑制剂瑞米布替尼在III期RMS临床试验中显著降低复发率 安全性表现良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815045","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815045?lang=zh_cn&edition=fundamental","pubTime":"2026-09-02 19:11","pubTimestamp":1788347485,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","IE0002141913.USD","BK4532","IE00BJJMRZ35.SGD","NVS","BK4588","IE00B2B36J28.USD","IE00B4R5TH58.HKD","PPH","BK4578","MDTX","MEDX","IE00BFTCPJ56.SGD","LU0208291251.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","IBBJ","LU0070302665.USD","PSYK","BK4007","IE0009355771.USD","LU0211331839.USD","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816902","title":"苏州市委书记范波会见强生执行副总裁史明德一行","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816902","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664816902?lang=zh_cn&edition=fundamental","pubTime":"2026-09-02 19:04","pubTimestamp":1788347047,"startTime":"0","endTime":"0","summary":"南方财经9月2日电，据苏州日报，9月2日，苏州市委书记范波会见了强生执行副总裁、医疗科技全球主席史明德一行，共同出席强生苏州20周年活动。强生公司是《财富》世界500强，是全球医疗健康行业头部企业，2006年落户苏州以来，不断增资扩产，推动强生苏州产业园发展成为强生医疗科技在华最大的供应链基地。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609023862919472.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609023862919472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GDOC","LU0320765646.SGD","LU1674673428.USD","BK4588","IE00BFTCPJ56.SGD","LU1894683348.USD","LU2430703095.HKD","BK4532","LU0795875169.SGD","FHLC","IXJ","LU1066051498.USD","IE00B2B36J28.USD","LU1228905037.USD","LU1989771016.USD","LU2505996681.GBP","LU1506573853.SGD","BK4581","MEDX","PJP","IE00BBT3K403.USD","LU1280957306.USD","IHE","LU2129689605.HKD","LU0124676726.USD","BK4504","BMED","LU1929549753.HKD","LU1032955483.USD","IE0000B7K699.USD","TRUH","LU1043141123.HKD","VHT","BK4585","LU2236285917.USD","RXL","IYH","LU2471134796.USD","LU0820561909.HKD","LU2129689514.USD","LU1061106388.HKD","JDOC","XLV","LU1043141396.HKD","LU2505996509.AUD","IE0034235303.USD","JNJ","LU1066051811.HKD","FTXH","LU1914381329.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818429","title":"众生药业(002317.SZ)：昂拉地韦片新增适应症临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818429","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818429?lang=zh_cn&edition=fundamental","pubTime":"2026-09-02 17:59","pubTimestamp":1788343190,"startTime":"0","endTime":"0","summary":"智通财经APP讯，众生药业(002317.SZ)发布公告，近日，公司控股子公司广东众生睿创生物科技有限公司自主研发的一类创新药物昂拉地韦片新增适应症“治疗高并发症风险甲型流感”的药物临床试验申请获得国家药品监督管理局(NMPA)受理，并收到《受理通知书》。据悉，昂拉地韦片是具有明确作用机制和全球自主知识产权的全球首款流感RNA聚合酶PB2蛋白抑制剂，已于2025年5月获NMPA批准上市。此次昂拉地韦片新增适应症拟开展III期临床研究入组12岁及以上青少年和成人甲型流感参与者，评估昂拉地韦片治疗甲型流感病毒感染且存在流感相关并发症高风险参与者的有效性和安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BMED","BK0239","002317","BK0188","IBBJ","PSYK","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664652890","title":"范波会见强生执行副总裁史明德一行，共同出席强生苏州20周年活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2664652890","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664652890?lang=zh_cn&edition=fundamental","pubTime":"2026-09-02 17:21","pubTimestamp":1788340918,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FHLC","LU0234572021.USD","IE000M9KFDE8.USD","LU1121112475.USD","LU0320765646.SGD","LU1066053197.SGD","LU1221951046.USD","IHE","IE000WAW04H5.SGD","IE00B42XCP33.USD","LU1066051811.HKD","VHT","LU1629891620.HKD","LU0070217475.USD","LU2468319806.SGD","BK4533","BMED","LU2347655156.SGD","BK4504","LU2592432038.USD","JDOC","MEDX","JNJ","PJP","IE00BGHQF631.EUR","LU1228905037.USD","LU0964807845.USD","LU2430703178.SGD","TRUH","FTXH","LU2750360997.AUD","LU0345769128.USD","IE00BZ1G4Q59.USD","BK4581","IE00B19Z3B42.SGD","XLV","LU0289739699.SGD","LU0792757196.USD","BK4568","GDOC","IE00B3T34201.USD","IE000MB6IJN5.SGD","LU1732800096.USD","RXL","LU2417539215.USD","LU2129689431.USD","IXJ","LU0122379950.USD","LU1718418525.SGD","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664897083","title":"国家药监局正式启动滴眼剂一致性评价工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2664897083","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664897083?lang=zh_cn&edition=fundamental","pubTime":"2026-09-02 17:13","pubTimestamp":1788340392,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","PSYK","MDTX","IBBJ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664589566","title":"单日暴涨177%的莫德纳，对全球医药产业意味着什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2664589566","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664589566?lang=zh_cn&edition=fundamental","pubTime":"2026-09-02 12:10","pubTimestamp":1788322216,"startTime":"0","endTime":"0","summary":"引发一切的，是当天莫德纳与默沙东联合公布的一份三期临床试验顶线结果。177%不是一天涨出来的要更进一步理解此次大涨，需要先理解市场之前对莫德纳的评判逻辑。默沙东为此等了十年，2016年签下合作协议并支付2亿美元首付款，2018年追加1.25亿美元战略投资，2022年正式行使共同开发选择权。8月20日下跌23.55%之后，莫德纳并没有跌回去。这里值得单独一提的是8月20日涨幅最大的云顶新耀，这","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788143888266092586","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0106261372.USD","LU2433249047.HKD","BK1161","LU2125154935.USD","LU0124676726.USD","BK4548","LU0965508806.USD","BK4559","LU1116320901.HKD","SG9999001176.SGD","IYH","IDNA","LU2361045086.USD","SG9999014567.USD","MRK","LU0058720904.USD","LU0266013472.USD","LU2125909593.SGD","IE00BJT1NW94.SGD","LU1989771016.USD","FTXH","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU1116320737.USD","FHLC","LU2125909247.SGD","SG9999001440.SGD","LU2461242641.AUD","LU0965509101.SGD","SG9999014542.SGD","LU0477156953.USD","LU2324357040.USD","SG9999002232.USD","SGXZ57979304.SGD","SG9999002224.SGD","LU1061106388.HKD","BNTX","IE000M9KFDE8.USD","LU1934455863.HKD","LU1430594728.SGD","IE00B1BXHZ80.USD","SG9999015341.SGD","LU1989772840.SGD","LU0070302665.USD","PPH","LU1941712348.USD","LU1201861249.SGD","GDOC","LU0965509010.AUD","LU0320765646.SGD","BK4532","LU0208291251.USD","LU1066051811.HKD","LU1035773651.USD","LU1929549753.HKD","SG9999014559.SGD","BMED","LU0868494708.USD","LU1093756168.USD","IE00BBT3K403.USD","MRNX","MRNA","LU0965509283.SGD","GNOM","LU0130517989.USD","LU0985320562.USD","BK4550","LU2468319806.SGD","HRTS","IXJ","SG9999014575.USD","XLV","LU1585245621.USD","IE00B2B36J28.USD","LU2491050154.USD","IE00BLSP4452.SGD","TRUH","LU1291159041.SGD","LU2023250843.SGD","LU1066053197.SGD","LU0122379950.USD","LU0320765489.SGD","IE00B4R5TH58.HKD","MRNY","IE00BLSP4239.USD","BK4007","IE0002141913.USD","LU1069347547.HKD","LU1983299246.USD","LU2491050071.SGD","LU0432979614.USD","PAWZ","LU2491049909.HKD","LU1934455277.USD","JDOC","LU1037948897.HKD","LU1066051498.USD","LU0265550359.USD","BK1574","IHE","BK4551","BK4535","SG9999001176.USD","01952","LU0130102774.USD","RXL","LU2089984988.USD","LU0238689110.USD","LU1057294990.SGD","LU2361044865.SGD","LU0861579265.USD","LU0203347892.USD","LU0689626769.HKD","LU0823416689.USD","IE00BFTCPJ56.SGD","LU0203345920.USD","VHT","LU1699723380.USD","BK4585","LU0980610538.SGD","BK4588","LU1032466523.USD","BK4533","LU1066051225.USD","LU1923622614.USD","BK4139","BK4568","LU2361044949.HKD","LGHT","BK4516","LU0868494617.USD","LU1989772923.USD","SG9999013999.USD","IE0009355771.USD","LU1037948541.HKD","LU0859254822.USD","LU1917777945.USD","LU1162221912.USD","LU0098860793.USD","WDNA","LU2360032135.SGD","BK1583","LU1571399168.USD","LU1974910355.USD","SG9999015358.SGD","LU0289739699.SGD","LU0006306889.USD","BK4534","LU1934455194.USD","LU0234572021.USD","LU1941712264.USD","LU1023059063.AUD","LU0648001328.SGD","LU0942090050.USD","IE00BN8TJ469.HKD","LU2112291526.USD","LU2125154778.USD","LU0211331839.USD","BK4501","LU0265550946.USD","LU2357627491.SGD","LU2023250504.SGD","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664860837","title":"澳大利亚批准金佰利·克拉克收购肯维尤，但要求其剥离“Carefree”和“Stayfree”品牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2664860837","media":"路透中文","labels":["corporation","policyRegulatory","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664860837?lang=zh_cn&edition=fundamental","pubTime":"2026-09-02 09:20","pubTimestamp":1788312053,"startTime":"0","endTime":"0","summary":"澳大利亚批准金佰利·克拉克收购肯维尤，但要求其剥离“Carefree”和“Stayfree”品牌路透9月2日-澳大利亚竞争监管机构周三批准了金佰利·克拉克KMB.O拟以400亿美元收购肯维尤KVUE.N的交易，但条件是该公司必须剥离肯维尤在澳大利亚的Carefree和Stayfree经期护理品牌，以消除竞争方面的担忧。据  上周报道，金佰利·克拉克还已向欧盟监管机构申请批准此次收购，欧盟委员会网站上的文件显示了这一情况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4S44U042:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,policyRegulatory,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","LU0820561909.HKD","GLAM","LU1066051811.HKD","MEDX","FHLC","JDOC","KMB","IE00BLSP4239.USD","IE00BFTCPJ56.SGD","LU2505996509.AUD","XLV","LU2430703095.HKD","LU0889566641.SGD","JNJ","LU1059921491.USD","LU0124676726.USD","LU0795875169.SGD","LU2129689431.USD","LU2236285917.USD","IYH","SG9999001440.SGD","LU2471134796.USD","IE00BVYPNV92.GBP","FTXH","LU1674673691.USD","TRUH","IE0000B7K699.USD","GDOC","BK4533","IE0002141913.USD","LU1629891620.HKD","VHT","IE00BLSP4452.SGD","IXJ","LU0310800379.SGD","LU0234570918.USD","RSPS","IE00BBT3K403.USD","LU0882574055.USD","LU0345770993.USD","KVUE","LU1778281490.HKD","LU1894683348.USD","PJP","LU1267930573.SGD","IHE","BK4183","RXL","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664860830","title":"澳大利亚批准金佰利·克拉克收购肯维尤，但要求其剥离“Carefree”和“Stayfree”品牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2664860830","media":"路透中文","labels":["corporation","policyRegulatory","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664860830?lang=zh_cn&edition=fundamental","pubTime":"2026-09-02 09:20","pubTimestamp":1788312053,"startTime":"0","endTime":"0","summary":"澳大利亚批准金佰利·克拉克收购肯维尤，但要求其剥离“Carefree”和“Stayfree”品牌路透9月2日-澳大利亚竞争监管机构周三批准了金佰利·克拉克KMB.O拟以400亿美元收购肯维尤KVUE.N的交易，但条件是该公司必须剥离肯维尤在澳大利亚的Carefree和Stayfree经期护理品牌，以消除竞争方面的担忧。据  上周报导，金佰利·克拉克还已向欧盟监管机构申请批准此次收购，欧盟委员会网站上的文件显示了这一情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4T44U042:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,policyRegulatory,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2505996509.AUD","BMED","LU1066051811.HKD","GDOC","MEDX","IE00BFTCPJ56.SGD","RXL","LU1674673691.USD","LU2236285917.USD","LU0795875169.SGD","IE0002141913.USD","LU1629891620.HKD","GLAM","VHT","IHE","LU1267930573.SGD","LU1894683348.USD","BK4183","LU2129689431.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU2430703095.HKD","TRUH","JDOC","LU0820561909.HKD","LU0124676726.USD","PJP","FTXH","SG9999001440.SGD","LU0345770993.USD","LU1059921491.USD","IE00BLSP4452.SGD","IE00BKVL7J92.USD","FHLC","XLV","LU0310800379.SGD","LU1778281490.HKD","IE0000B7K699.USD","IYH","LU2471134796.USD","LU0889566641.SGD","LU0882574055.USD","BK4533","JNJ","LU0234570918.USD","RSPS","KMB","KVUE","IE00BVYPNV92.GBP","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181076454","title":"世卫组织：尔韦博疫苗目前仅应在研究方案框架内用于本迪布焦病毒（BVDV）","url":"https://stock-news.laohu8.com/highlight/detail?id=1181076454","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181076454?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 23:35","pubTimestamp":1788276944,"startTime":"0","endTime":"0","summary":"世界卫生组织（WHO）表示，尔韦博（Ervebo）疫苗现阶段仅可在研究性方案框架下，用于针对本迪布焦病毒（Bundibugyo Virus, BVDV）的防控。这一表态凸显了该疫苗在当前阶段使用的严格限定条件——其应用范围被明确框定于科学研究的语境之内，而非广泛的常规接种。换言之，任何涉及此疫苗应对BVDV的举措，都必须依托于严谨的研究设计，以确保数据的完整性与安全性评估的可靠性。此间，专家亦强调，这种审慎态度反映出对新型疫苗在不同病毒株间交叉保护效力的未知性，以及循证决策的必要性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU1929549753.HKD","LU1066051225.USD","SG9999001176.SGD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU2433249047.HKD","LU1699723380.USD","LU1066051811.HKD","IE00B1BXHZ80.USD","LU2491049909.HKD","BK4588","BK4007","VHT","SG9999001440.SGD","LU0965509010.AUD","LU0203345920.USD","RXL","LU0203347892.USD","LU0234572021.USD","LU2360032135.SGD","SG9999013999.USD","LU0868494708.USD","HRTS","LU0124676726.USD","LU1983299246.USD","PAWZ","LU2125909247.SGD","LU0965509283.SGD","SG9999014542.SGD","LU2106854487.HKD","LU0211331839.USD","BK4534","LU1066051498.USD","LU2491050071.SGD","IE00B4R5TH58.HKD","BK4559","LU2361044949.HKD","LU1032466523.USD","IE00BFTCPJ56.SGD","LU0265550359.USD","LU2361045086.USD","LU1291159041.SGD","LU2023250504.SGD","IHE","BMED","IXJ","LU0098860793.USD","LU2361044865.SGD","LU0942090050.USD","LU1934455863.HKD","LU2125154778.USD","LU0106261372.USD","BK4550","IE000M9KFDE8.USD","LU1035773651.USD","LU0859254822.USD","SG9999002224.SGD","LU2491050154.USD","SG9999014575.USD","LU2023250843.SGD","LU1989772840.SGD","LU0208291251.USD","IE00BLSP4239.USD","LU1162221912.USD","LU0965508806.USD","IE00BBT3K403.USD","LU0070302665.USD","LU0058720904.USD","LU0965509101.SGD","LU1069347547.HKD","BK4516","LU1201861249.SGD","IE00BN8TJ469.HKD","LU0980610538.SGD","LU1941712348.USD","LU0122379950.USD","LU1093756325.SGD","LU1057294990.SGD","SG9999014559.SGD","LU0320765646.SGD","LU0238689110.USD","IE00B2B36J28.USD","IE0002141913.USD","LU1585245621.USD","LU0265550946.USD","LU1116320901.HKD","LU1037948541.HKD","LU0823416689.USD","MRK","LU0006306889.USD","LU1934455194.USD","BK4533","LU2461242641.AUD","LU0266013472.USD","LU0985320562.USD","PPH","JDOC","LU1093756168.USD","LU1941712264.USD","LU2125909593.SGD","LU1023059063.AUD","SG9999015358.SGD","LU0477156953.USD","IE0009355771.USD","LU1923622614.USD","LU0289739699.SGD","LU1934455277.USD","LU0689626769.HKD","LU2125154935.USD","LU0130102774.USD","LU1974910355.USD","LU0130517989.USD","FTXH","LU2468319806.SGD","SG9999014567.USD","LU0320765489.SGD","IE00BLSP4452.SGD","SG9999002232.USD","IE00BSNM7G36.USD","LU1116320737.USD","LU2112291526.USD","TRUH","FHLC","LU0648001328.SGD","LU1917777945.USD","LU2357627491.SGD","BK4585","LU1061106388.HKD","LU1037948897.HKD","LU0861579265.USD","LU1571399168.USD","LU1989772923.USD","LU0868494617.USD","SG9999001176.USD","XLV","LU0432979614.USD","LU1430594728.SGD","SG9999015341.SGD","GDOC","SGXZ57979304.SGD","IYH","LU1989771016.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664355858","title":"石药集团(01093.HK)：SYH2056片用于治疗抑郁症的I期临床试验在中国正式启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2664355858","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664355858?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 18:12","pubTimestamp":1788257547,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","PSYK","MDTX","BMED","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832774","title":"智飞生物(300122.SZ)：冻干人用狂犬病疫苗(ZFB-3细胞)临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832774","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832774?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 17:05","pubTimestamp":1788253557,"startTime":"0","endTime":"0","summary":"智通财经APP讯，智飞生物(300122.SZ)发布公告，公司于近日获悉，由全资子公司安徽智飞龙科马生物制药有限公司研发的冻干人用狂犬病疫苗(ZFB-3细胞)获得国家药品监督管理局药物临床试验申请受理通知书。该药品用于预防狂犬病。通过接种该疫苗，可剌激机体产生抗狂犬病病毒的免疫力。该药品以公司自主研制的人二倍体细胞株(ZFB-3细胞)作为生产基质，与动物源性细胞狂犬病疫苗相比，理论上局部和全身不良反应发生率更小，且无致瘤性风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDTX","LU1064130708.USD","LU2148510915.USD","300122","BK0188","LU1328615791.USD","PSYK","LU2580892789.USD","BK0239","BK0077","BK0196","BMED","IBBJ","IBBQ","LU2580892862.HKD","LU1064131003.USD","BK0046","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664083225","title":"中关村(000931.SZ)下属公司盐酸哌甲酯缓释咀嚼片获批开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2664083225","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664083225?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 16:59","pubTimestamp":1788253144,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中关村(000931.SZ)发布公告，公司下属公司北京华素制药股份有限公司(简称：北京华素)于近日收到国家药品监督管理局核准签发的盐酸哌甲酯缓释咀嚼片(规格：40mg)《药物临床试验批准通知书》。该药品拟开展用于注意缺陷多动障碍(ADHD)的临床试验。截至目前，中国境内仅1家原研进口获批上市，北京华素为国内第一家获批本品仿制药临床试验许可的企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BMED","BK0178","BK0075","000931","IBBJ","BK0239","IBBQ","MDTX","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664083291","title":"智飞生物：智飞龙科马疫苗临床试验申请获受理，60日内可开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2664083291","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664083291?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 16:53","pubTimestamp":1788252835,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","IBBQ","BMED","PRTO","PSYK","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664329148","title":"中关村：北京华素40mg盐酸哌甲酯缓释咀嚼片获准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2664329148","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664329148?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 16:53","pubTimestamp":1788252832,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","BMED","PSYK","IBBJ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831619","title":"诺华制药(NVS.US)神经免疫管线“悲喜交加”：患者死亡致CAR-T临床试验暂停 MS口服药后期试验告捷","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831619","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831619?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 15:40","pubTimestamp":1788248407,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺华制药在神经与自身免疫领域迎来“冰火两重天”：公司因三名患者死亡紧急叫停八项CAR-T疗法临床试验;不过，其多发性硬化症口服药remibrutinib在后期临床试验中取得积极结果。CAR-T试验紧急暂停诺华制药在8月底暂停了八项针对自身免疫和神经系统疾病的实验性疗法临床试验，此前有三名患者死亡。诺华制药发言人表示，公司正在“对所观察到的安全事件进行全面审查”，并将这种致命免疫反应描述为CAR-T疗法中已知的安全风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PSYK","BK4578","MDTX","BK1191","MEDX","BMED","01477","IE00B2B36J28.USD","BK1574","IE00BFTCPJ56.SGD","BK4532","BK4588","LU0320765489.SGD","LU0070302665.USD","IE00B4R5TH58.HKD","BK4585","LU0208291251.USD","IE00BJT1NW94.SGD","IE0002141913.USD","PPH","IE0009355771.USD","IE00BJJMRZ35.SGD","NVS","LU0211331839.USD","BK4007","IBBQ","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664183676","title":"默克集团股价上涨2.6%，此前汇丰银行将其评级从持有上调至买入。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664183676","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664183676?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 15:04","pubTimestamp":1788246292,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1066051225.USD","LU1037948541.HKD","LU0868494617.USD","IE00BJT1NW94.SGD","TRUH","LU1093756325.SGD","LU2491049909.HKD","LU1571399168.USD","LU1934455194.USD","LU2125909593.SGD","LU2125154778.USD","LU2361044949.HKD","LU0985320562.USD","IE00BJJMRZ35.SGD","LU1989771016.USD","LU1162221912.USD","LU2357627491.SGD","LU1934455277.USD","LU0238689110.USD","BK4007","LU1057294990.SGD","LU0211331839.USD","LU1917777945.USD","LU1699723380.USD","LU0266013472.USD","LU1989772840.SGD","IE00BN8TJ469.HKD","LU0868494708.USD","LU2491050154.USD","JDOC","LU0124676726.USD","LU1941712264.USD","RXL","IE00B4R5TH58.HKD","LU0122379950.USD","LU1066051498.USD","LU1061106388.HKD","HRTS","LU0320765646.SGD","LU1035773651.USD","LU0859254822.USD","SG9999002224.SGD","PPH","SG9999001176.USD","IE0009355771.USD","SG9999002232.USD","SG9999001176.SGD","LU1974910355.USD","SG9999014542.SGD","BK4534","SG9999014575.USD","LU1116320901.HKD","LU1066051811.HKD","SG9999015358.SGD","LU0070302665.USD","LU0106261372.USD","LU0234572021.USD","LU2125154935.USD","LU0965509101.SGD","LU2433249047.HKD","VHT","LU0432979614.USD","LU0861579265.USD","IE00BSNM7G36.USD","GDOC","LU1032466523.USD","LU1934455863.HKD","FHLC","LU2023250504.SGD","BK4559","BK4516","SGXZ57979304.SGD","IE00BLSP4239.USD","LU2461242641.AUD","LU2112291526.USD","LU2023250843.SGD","LU2089984988.USD","FTXH","LU2106854487.HKD","LU1585245621.USD","IE00B1BXHZ80.USD","LU0265550359.USD","BK4585","IE00BLSP4452.SGD","LU1023059063.AUD","LU1201861249.SGD","LU0130102774.USD","LU0320765489.SGD","LU0006306889.USD","LU2361044865.SGD","LU0965509010.AUD","LU0265550946.USD","SG9999015341.SGD","BMED","LU2324357040.USD","LU1929549753.HKD","IYH","LU2468319806.SGD","LU1983299246.USD","IE00B2B36J28.USD","BK4533","XLV","LU0058720904.USD","LU0098860793.USD","SG9999014567.USD","LU1291159041.SGD","IE000M9KFDE8.USD","BK4550","SG9999014559.SGD","LU0203345920.USD","LU0823416689.USD","LU1430594728.SGD","LU0965508806.USD","LU0980610538.SGD","LU0965509283.SGD","LU0689626769.HKD","LU2360032135.SGD","LU1066053197.SGD","LU2361045086.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0203347892.USD","LU1116320737.USD","PAWZ","SG9999013999.USD","LU1923622614.USD","LU2491050071.SGD","SG9999001440.SGD","LU1093756168.USD","LU1037948897.HKD","LU0208291251.USD","LU0648001328.SGD","IE0002141913.USD","IE00BBT3K403.USD","LU1989772923.USD","LU0942090050.USD","LU0477156953.USD","LU1069347547.HKD","LU1941712348.USD","LU2125909247.SGD","IXJ","LU0130517989.USD","MRK","BK4588","IHE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882342","title":"吉伦泰研制的靶向整合素αvβ3治疗核药获得国家药监局临床试验批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882342","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664882342?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 09:52","pubTimestamp":1788227549,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","MDTX","PSYK","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664008470","title":"美国医疗保险和医疗补助服务中心：将为阿肯色州农村医院提供资金，用于升级救护车、拓展远程医疗服务并安装应急发电机","url":"https://stock-news.laohu8.com/highlight/detail?id=2664008470","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664008470?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 02:18","pubTimestamp":1788200331,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["UNHG","BK4585","SG9999014013.SGD","BMED","LU1093756325.SGD","IHF","RSPH","LU0390134368.USD","FDHT","LU0348723411.USD","UNHU","LU0170899867.USD","LU0208291251.USD","LU0211331839.USD","UN","LU0417517546.SGD","HTEC","LGHT","UNHW","BK4588","IEHS","HEAL","LU0256863811.USD","BK4154","LU0320765489.SGD","HUM","EKG","SG9999014021.USD","SG9999014005.SGD","IEIH","LU1093756168.USD","GDOC","LU0266013472.USD","LU1983260115.SGD","LU0070302665.USD","BK4533","LU0238689110.USD","BK4566","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811000","title":"特朗普政府宣布拨款1.493亿美元，用于在阿肯色州农村地区扩展远程医疗，并增加专科护理和预防性筛查的可及性。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811000","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811000?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 02:17","pubTimestamp":1788200232,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","HEAL","FDHT","HTEC","LGHT","IEIH","EKG","GDOC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}